{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fideacollider.simplecast.com%2Fepisodes%2Fidea-collider-dan-skovronsky-Pz_D2KVt","width":444,"version":"1.0","type":"rich","title":"IDEA Collider | Dan Skovronsky","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/94bf3c6e-e92e-4780-a165-f429efcd3353/86f9ecf7-dcb0-4b65-90e0-34bf28931f7a/option_1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/e862d9d3-8c77-4633-9d86-13fe5b06531e\" height=\"200\" width=\"100%\" title=\"IDEA Collider | Dan Skovronsky\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this interview, we discuss Lilly's remarkable performance as the most innovative pharma company on the 2021 Pharmaceutical Innovation and Invention Index, about cultures of innovation, Lilly's approach to delegated decision making and biotech-like process, among other things. "}